A modified blood cell GAP (cGAP) to prognosticate outcomes in IPF
M. Kreuter (Heidelberg, Germany), J. Lee (Denver, United States), A. Tzouvelekis (Patras, Greece), J. Oldham (Sacramento, United States), P. Molyneaux (London, United Kingdom), D. Weycker (Brookline, United States), M. Atwood (Brookline, United States), K. Kirchgässler (Basel, Switzerland), T. Maher (Los Angeles, United States)
Source: International Congress 2022 – New tools for the diagnosis of interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kreuter (Heidelberg, Germany), J. Lee (Denver, United States), A. Tzouvelekis (Patras, Greece), J. Oldham (Sacramento, United States), P. Molyneaux (London, United Kingdom), D. Weycker (Brookline, United States), M. Atwood (Brookline, United States), K. Kirchgässler (Basel, Switzerland), T. Maher (Los Angeles, United States). A modified blood cell GAP (cGAP) to prognosticate outcomes in IPF. 3416
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|